{
  "ticker": "GILD",
  "year": 2023,
  "quarter": 1,
  "last_updated": "2025-04-15T14:53:27.739286",
  "count": 38,
  "transactions": [
    {
      "id": 67543,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2023-03-13",
      "transaction_shares": "6126",
      "transaction_price": "78.99",
      "transaction_type": "S",
      "shares_after_transaction": "70130"
    },
    {
      "id": 107173,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2023-03-13",
      "transaction_shares": "6126",
      "transaction_price": "78.99",
      "transaction_type": "S",
      "shares_after_transaction": "70130"
    },
    {
      "id": 67533,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2023-03-10",
      "transaction_shares": "1601",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "25693"
    },
    {
      "id": 67557,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2023-03-10",
      "transaction_shares": "3455",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "73585"
    },
    {
      "id": 67561,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2023-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "79390"
    },
    {
      "id": 67584,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2023-03-10",
      "transaction_shares": "19488",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "378983"
    },
    {
      "id": 67585,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2023-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "108643"
    },
    {
      "id": 107162,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2023-03-10",
      "transaction_shares": "1601",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "25693"
    },
    {
      "id": 107192,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2023-03-10",
      "transaction_shares": "3455",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "73585"
    },
    {
      "id": 107197,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2023-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "79390"
    },
    {
      "id": 107229,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2023-03-10",
      "transaction_shares": "19488",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "378983"
    },
    {
      "id": 107230,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2023-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "108643"
    },
    {
      "id": 67562,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Lofton Kevin E",
      "reporting_owner_cik": "0001468818",
      "reporting_owner_position": null,
      "transaction_date": "2023-03-09",
      "transaction_shares": "8442",
      "transaction_price": "52.38",
      "transaction_type": "M",
      "shares_after_transaction": "8442"
    },
    {
      "id": 107198,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Lofton Kevin E",
      "reporting_owner_cik": "0001468818",
      "reporting_owner_position": null,
      "transaction_date": "2023-03-09",
      "transaction_shares": "8442",
      "transaction_price": "52.38",
      "transaction_type": "M",
      "shares_after_transaction": "8442"
    },
    {
      "id": 67534,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2023-03-01",
      "transaction_shares": "12984",
      "transaction_price": "79.9619",
      "transaction_type": "S",
      "shares_after_transaction": "70130"
    },
    {
      "id": 67538,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2023-03-01",
      "transaction_shares": "11362",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "364337"
    },
    {
      "id": 107163,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2023-03-01",
      "transaction_shares": "12984",
      "transaction_price": "79.9619",
      "transaction_type": "S",
      "shares_after_transaction": "70130"
    },
    {
      "id": 107168,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2023-03-01",
      "transaction_shares": "11362",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "364337"
    },
    {
      "id": 67550,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2023-02-15",
      "transaction_shares": "376",
      "transaction_price": "56.3805",
      "transaction_type": "A",
      "shares_after_transaction": "376"
    },
    {
      "id": 67559,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2023-02-15",
      "transaction_shares": "376",
      "transaction_price": "56.3805",
      "transaction_type": "A",
      "shares_after_transaction": "83114"
    },
    {
      "id": 67570,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2023-02-15",
      "transaction_shares": "376",
      "transaction_price": "56.3805",
      "transaction_type": "A",
      "shares_after_transaction": "105618"
    },
    {
      "id": 107183,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2023-02-15",
      "transaction_shares": "376",
      "transaction_price": "56.3805",
      "transaction_type": "A",
      "shares_after_transaction": "376"
    },
    {
      "id": 107195,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2023-02-15",
      "transaction_shares": "376",
      "transaction_price": "56.3805",
      "transaction_type": "A",
      "shares_after_transaction": "83114"
    },
    {
      "id": 107209,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2023-02-15",
      "transaction_shares": "376",
      "transaction_price": "56.3805",
      "transaction_type": "A",
      "shares_after_transaction": "105618"
    },
    {
      "id": 67563,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2023-02-06",
      "transaction_shares": "1817",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "105773"
    },
    {
      "id": 67587,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Wilfong Diane E.",
      "reporting_owner_cik": "0001374988",
      "reporting_owner_position": "SVP, Controller & CAO",
      "transaction_date": "2023-02-06",
      "transaction_shares": "1864",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "32575"
    },
    {
      "id": 107200,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2023-02-06",
      "transaction_shares": "1817",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "105773"
    },
    {
      "id": 107232,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Wilfong Diane E.",
      "reporting_owner_cik": "0001374988",
      "reporting_owner_position": "SVP, Controller & CAO",
      "transaction_date": "2023-02-06",
      "transaction_shares": "1864",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "32575"
    },
    {
      "id": 67530,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2023-01-24",
      "transaction_shares": "27932",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "81013"
    },
    {
      "id": 67548,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2023-01-24",
      "transaction_shares": "29644",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "56772"
    },
    {
      "id": 67551,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Wilfong Diane E.",
      "reporting_owner_cik": "0001374988",
      "reporting_owner_position": "SVP, Controller & CAO",
      "transaction_date": "2023-01-24",
      "transaction_shares": "1784",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "27855"
    },
    {
      "id": 67577,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2023-01-24",
      "transaction_shares": "78370",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "275406"
    },
    {
      "id": 67579,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2023-01-24",
      "transaction_shares": "29124",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "53420"
    },
    {
      "id": 107159,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2023-01-24",
      "transaction_shares": "27932",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "81013"
    },
    {
      "id": 107181,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2023-01-24",
      "transaction_shares": "29644",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "56772"
    },
    {
      "id": 107185,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Wilfong Diane E.",
      "reporting_owner_cik": "0001374988",
      "reporting_owner_position": "SVP, Controller & CAO",
      "transaction_date": "2023-01-24",
      "transaction_shares": "1784",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "27855"
    },
    {
      "id": 107222,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2023-01-24",
      "transaction_shares": "78370",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "275406"
    },
    {
      "id": 107224,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2023-01-24",
      "transaction_shares": "29124",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "53420"
    }
  ]
}